U.S. markets closed
  • S&P 500

    4,395.26
    -23.89 (-0.54%)
     
  • Dow 30

    34,935.47
    -149.06 (-0.42%)
     
  • Nasdaq

    14,672.68
    -105.59 (-0.71%)
     
  • Russell 2000

    2,226.25
    -13.78 (-0.62%)
     
  • Crude Oil

    73.81
    +0.19 (+0.26%)
     
  • Gold

    1,812.50
    -18.70 (-1.02%)
     
  • Silver

    25.55
    -0.23 (-0.90%)
     
  • EUR/USD

    1.1871
    -0.0025 (-0.21%)
     
  • 10-Yr Bond

    1.2390
    -0.0300 (-2.36%)
     
  • GBP/USD

    1.3906
    -0.0051 (-0.37%)
     
  • USD/JPY

    109.6150
    +0.1540 (+0.14%)
     
  • BTC-USD

    41,425.59
    +1,823.82 (+4.61%)
     
  • CMC Crypto 200

    955.03
    +5.13 (+0.54%)
     
  • FTSE 100

    7,032.30
    -46.12 (-0.65%)
     
  • Nikkei 225

    27,283.59
    -498.83 (-1.80%)
     

INVESTIGATION ALERT: Halper Sadeh LLP Investigates KSU, INSW, LMNX, XERS; Shareholders are Encouraged to Contact the Firm

·2 min read

NEW YORK, NY / ACCESSWIRE / May 27, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

Kansas City Southern (NYSE:KSU) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to the sale of the company. If you are a Kansas City shareholder, click here to learn more about your rights and options.

International Seaways, Inc. (NYSE:INSW) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Diamond S Shipping Inc. Upon completion of the merger, International Seaways shareholders are expected to own approximately 55.75% of the combined company. If you are an International Seaways shareholder, click here to learn more about your rights and options.

Luminex Corporation (NASDAQ:LMNX) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to DiaSorin S.p.A. for $37.00 per share. If you are a Luminex shareholder, click here to learn more about your rights and options.

Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Strongbridge Biopharma plc. Upon closing, Xeris shareholders will exchange each share of Xeris common stock they own for 1 share of the combined company. Current Xeris shareholders are expected to own approximately 60% of the combined company. If you are a Xeris shareholder, click here to learn more about your rights and options.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

SOURCE: Halper Sadeh LLP



View source version on accesswire.com:
https://www.accesswire.com/649446/INVESTIGATION-ALERT-Halper-Sadeh-LLP-Investigates-KSU-INSW-LMNX-XERS-Shareholders-are-Encouraged-to-Contact-the-Firm